PTPA and cancer: Based on the functions and mechanisms of CIP2A activation in human cancers, the therapeutic targeting of CIP2A could facilitate a novel strategy for cancer therapy, including the use of CIP2A small RNA interference technology or the development of small molecules that target the CIP2A-PP2A interaction [6,31].